These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 25414270

  • 1. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.
    Freeman JV, Reynolds K, Fang M, Udaltsova N, Steimle A, Pomernacki NK, Borowsky LH, Harrison TN, Singer DE, Go AS.
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):49-58. PubMed ID: 25414270
    [Abstract] [Full Text] [Related]

  • 2. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.
    Adedinsewo D, Xu J, Agasthi P, Oderinde A, Adekeye O, Sachdeva R, Rust G, Onwuanyi A.
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004573. PubMed ID: 28500174
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure.
    Freeman JV, Yang J, Sung SH, Hlatky MA, Go AS.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):525-33. PubMed ID: 24021697
    [Abstract] [Full Text] [Related]

  • 4. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowitz SD, Nessel CC, Fox KA, Califf RM, Piccini JP, Patel MR, ROCKET AF Steering Committee and Investigators.
    Lancet; 2015 Jun 13; 385(9985):2363-70. PubMed ID: 25749644
    [Abstract] [Full Text] [Related]

  • 5. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Behlouli H, Pilote L.
    Am J Cardiol; 2014 Aug 01; 114(3):401-6. PubMed ID: 24950677
    [Abstract] [Full Text] [Related]

  • 6. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
    Mulder BA, Van Veldhuisen DJ, Crijns HJ, Tijssen JG, Hillege HL, Alings M, Rienstra M, Van den Berg MP, Van Gelder IC, RACE II Investigators.
    Heart Rhythm; 2014 Sep 01; 11(9):1543-50. PubMed ID: 24924587
    [Abstract] [Full Text] [Related]

  • 7. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.
    Turakhia MP, Santangeli P, Winkelmayer WC, Xu X, Ullal AJ, Than CT, Schmitt S, Holmes TH, Frayne SM, Phibbs CS, Yang F, Hoang DD, Ho PM, Heidenreich PA.
    J Am Coll Cardiol; 2014 Aug 19; 64(7):660-8. PubMed ID: 25125296
    [Abstract] [Full Text] [Related]

  • 8. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
    Gheorghiade M, Fonarow GC, van Veldhuisen DJ, Cleland JG, Butler J, Epstein AE, Patel K, Aban IB, Aronow WS, Anker SD, Ahmed A.
    Eur Heart J; 2013 May 19; 34(20):1489-97. PubMed ID: 23592708
    [Abstract] [Full Text] [Related]

  • 9. Predictive value of the heart rate reserve in patients with permanent atrial fibrillation treated according to a strict rate-control strategy.
    De Schryver N, Scavée C, Marchandise S, Pasquet A, de Meester C, le Polain de Waroux JB.
    Europace; 2014 Aug 19; 16(8):1125-30. PubMed ID: 24599938
    [Abstract] [Full Text] [Related]

  • 10. Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry.
    Gao Y, Chang S, Du X, Dong J, Xu X, Zhou Y, Lip GYH, Ma C.
    Am J Cardiovasc Drugs; 2019 Dec 19; 19(6):579-587. PubMed ID: 31077081
    [Abstract] [Full Text] [Related]

  • 11. Interaction between digoxin and dronedarone in the PALLAS trial.
    Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ, PALLAS investigators.
    Circ Arrhythm Electrophysiol; 2014 Dec 19; 7(6):1019-25. PubMed ID: 25378467
    [Abstract] [Full Text] [Related]

  • 12. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Pastori D, Farcomeni A, Bucci T, Cangemi R, Ciacci P, Vicario T, Violi F, Pignatelli P.
    Int J Cardiol; 2015 Feb 01; 180():1-5. PubMed ID: 25460369
    [Abstract] [Full Text] [Related]

  • 13. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
    Hallberg P, Lindbäck J, Lindahl B, Stenestrand U, Melhus H, RIKS-HIA group.
    Eur J Clin Pharmacol; 2007 Oct 01; 63(10):959-71. PubMed ID: 17684738
    [Abstract] [Full Text] [Related]

  • 14. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I, Panduranga P, Zubaid M, Sulaiman K, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, Shehab A, Al Qudaimi A, Asaad N, Amin H.
    J Cardiovasc Pharmacol Ther; 2016 May 01; 21(3):273-9. PubMed ID: 26341119
    [Abstract] [Full Text] [Related]

  • 15. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
    Friberg L, Hammar N, Rosenqvist M.
    Heart; 2010 Feb 01; 96(4):275-80. PubMed ID: 19710030
    [Abstract] [Full Text] [Related]

  • 16. Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.
    Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Boman K, Dahlöf B, Devereux RB.
    J Hypertens; 2015 Jul 01; 33(7):1480-6. PubMed ID: 25799208
    [Abstract] [Full Text] [Related]

  • 17. Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
    Whitbeck MG, Charnigo RJ, Khairy P, Ziada K, Bailey AL, Zegarra MM, Shah J, Morales G, Macaulay T, Sorrell VL, Campbell CL, Gurley J, Anaya P, Nasr H, Bai R, Di Biase L, Booth DC, Jondeau G, Natale A, Roy D, Smyth S, Moliterno DJ, Elayi CS.
    Eur Heart J; 2013 May 01; 34(20):1481-8. PubMed ID: 23186806
    [Abstract] [Full Text] [Related]

  • 18. [Association between duration of digoxin use and adverse outcomes among Chinese patients with atrial fibrillation].
    Chang SS, Gao Y, Xia SJ, Du X, Dong JZ, Ma CS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep 24; 48(9):728-734. PubMed ID: 32957754
    [Abstract] [Full Text] [Related]

  • 19. Digoxin and Mortality in Patients With Atrial Fibrillation.
    Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L, ARISTOTLE Committees and Investigators.
    J Am Coll Cardiol; 2018 Mar 13; 71(10):1063-1074. PubMed ID: 29519345
    [Abstract] [Full Text] [Related]

  • 20. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF, Liu CJ, Tuan TC, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Chen TJ, Chiang CE, Chen SA.
    Circulation; 2015 Oct 27; 132(17):1604-12. PubMed ID: 26384160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.